Phase 2 Study of Cemiplimab in Patients with Advanced Cutaneous Squamous Cell Carcinoma (CSCC): Longer Follow-Up. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 4, n. 6, p. s124, 2020. DOI: 10.25251/skin.4.supp.124. Disponível em: https://skin.dermsquared.com/skin/article/view/1097. Acesso em: 19 apr. 2025.